Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

180 Life Sciences Corp

Current price
1.62 USD -0.02 USD (-1.22%)
Last closed 1.62 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 525 375 USD
Yield for 12 month +40.87 %
21.11.2021 - 28.11.2021

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Palo Alto, California. Address: Building 4, Palo Alto, CA, United States, 94306

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

80 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

+166 030 USD

Current Year

-105 675 USD

Last Year

-109 004 USD

Current Quarter

-23 576 USD

Last Quarter

+143 370 USD

Key Figures ATNF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -10 658 644 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -73.28 %
PEG Ratio
Return On Equity TTM -525.19 %
Wall Street Target Price 80 USD
Revenue TTM
Book Value -1.12 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -30.12 USD
Diluted Eps TTM -30.12 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ATNF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ATNF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:19
Payout Ratio
Last Split Date 28.02.2024
Dividend Date

Stock Valuation ATNF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 6.079
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.0416
Price Book MRQ 0.3608

Financials ATNF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ATNF

For 52 weeks

1.33 USD 26.03 USD
50 Day MA 2.13 USD
Shares Short Prior Month 27 442
200 Day MA 5.88 USD
Short Ratio 0.28
Shares Short 17 263
Short Percent 1.85 %

Dynamics of changes in the value of assets




430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds



14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics



2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics